EFFECT OF A NEW DRUG, N-(2-ENDOBICYCLO-(2,2,1)-HEPTANE)-DIETHYLAMINOACETAMIDE HYDROCHLORIDE (ERL-239), ON MEAN ARTERIAL BLOOD PRESSURE, CARDIAC OUTPUT, CORONARY BLOOD FLOW, CARDIAC OXYGEN CONSUMPTION, WORK AND EFFICIENCY